GT Biopharma, Inc. (GTBP) › Shareholders' EquityGT Biopharma, Inc. (GTBP) — Shareholders' EquityAnnual figures by period end, from SEC filings.2010-12-31: -$5.47M2011-12-31: -$5.10M2012-12-31: -$6.34M2013-12-31: -$6.33M2014-12-31: -$29.57M2015-12-31: -$50.57M2016-12-31: -$18.92M2017-12-31: $251.69M2018-12-31: $11.37M2019-12-31: -$19.31M2020-06-30: -$27.50M2020-09-30: -$29.78M2020-12-31: -$29.43M2021-12-31: $21.91M2022-12-31: $11.73M2023-12-31: $7.48M2024-12-31: -$1.67M2025-06-30: -$25.88M2025-09-30: $3.00M2025-12-31: $5.79M$5.79M2010-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$5.79M—2026-03-02Balance as of period end2025-09-30$3.00M—2026-03-02Balance as of period end2025-06-30-$25.88M—2026-03-02Balance as of period end2024-12-31-$1.67M-122.3%2026-03-02Balance as of period end2023-12-31$7.48M-36.3%2026-03-02Balance as of period end2022-12-31$11.73M-46.4%2025-02-21Balance as of period end2021-12-31$21.91M—2024-03-26Balance as of period end2020-12-31-$29.43M—2023-03-30Balance as of period end2020-09-30-$29.78M—2021-04-16Balance as of period end2020-06-30-$27.50M—2021-04-16Balance as of period end2019-12-31-$19.31M-269.8%2022-03-28Balance as of period end2018-12-31$11.37M-95.5%2021-04-16Balance as of period end2017-12-31$251.69M—2019-03-29Balance as of period end2016-12-31-$18.92M—2018-03-01Balance as of period end2015-12-31-$50.57M—2018-02-28Balance as of period end2014-12-31-$29.57M—2018-02-28Balance as of period end2013-12-31-$6.33M—2015-03-31Balance as of period end2012-12-31-$6.34M—2015-01-08Balance as of period end2011-12-31-$5.10M—2014-11-18Balance as of period end2010-12-31-$5.47M—2012-04-16Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)